Is a Single Initial Procalcitonin Test Sufficient in Septic, Critically Ill Patients to Minimize Antibiotic Use?

Affiliations

¹ Department of Intensive Care Medicine, Elisabeth-TweeSteden Ziekenhuis, Tilburg, the Netherlands. Electronic address: jah.vanoers@etz.nl.
² Department of Intensive Care Medicine, VU University, Medical Center, Amsterdam, the Netherlands.
³ Department of Intensive Care Medicine, Medisch Spectrum Twente, Enschede, the Netherlands.
⁴ Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
⁵ Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.

Comment

Jos A H van Oers et al. Chest. 2017 Jul.

. 2017 Jul;152(1):218-219.

doi: 10.1016/j.chest.2017.03.062.

¹ Department of Intensive Care Medicine, Elisabeth-TweeSteden Ziekenhuis, Tilburg, the Netherlands. Electronic address: jah.vanoers@etz.nl.
² Department of Intensive Care Medicine, VU University, Medical Center, Amsterdam, the Netherlands.
³ Department of Intensive Care Medicine, Medisch Spectrum Twente, Enschede, the Netherlands.
⁴ Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
⁵ Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.

No abstract available

Comment in

Response.
Balk RA, Kadri SS, Cao Z, Robinson SB, Lipkin C, Bozzette SA. Balk RA, et al. Chest. 2017 Jul;152(1):219-220. doi: 10.1016/j.chest.2017.04.180. Chest. 2017. PMID: 28693772 Free PMC article. No abstract available.

Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States.
Balk RA, Kadri SS, Cao Z, Robinson SB, Lipkin C, Bozzette SA. Balk RA, et al. Chest. 2017 Jan;151(1):23-33. doi: 10.1016/j.chest.2016.06.046. Epub 2016 Aug 25. Chest. 2017. PMID: 27568580 Free PMC article.